All stock lists
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
Healthcare · Biotechnology
126.10+1.00 (+0.80%)
Insider Score
––Not scored
PVLA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PVLA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 8.93 M | 5.52 M | 4.18 M | 3.65 M | 4.13 M | 3.80 M |
| R&D Expense | 12.47 M | 9.33 M | 7.12 M | 6.53 M | 5.12 M | 4.07 M |
| Operating Expenses | 21.41 M | 14.86 M | 11.30 M | 10.18 M | 9.25 M | 7.87 M |
| Operating Income | -21.41 M | -14.86 M | -11.30 M | -10.18 M | -9.25 M | -7.87 M |
| Pretax Income | -21.87 M | -15.77 M | -12.71 M | -11.35 M | -9.47 M | -8.19 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -21.87 M | -15.77 M | -12.71 M | -11.35 M | -9.47 M | -8.19 M |
| EPS (Basic) | -1.52 | -1.20 | -1.08 | -1.03 | -0.86 | -3.68 |
| EPS (Diluted) | -1.52 | -1.20 | -1.08 | -1.03 | -0.86 | -3.68 |
| Shares Outstanding | 14.36 M | 13.09 M | 11.25 M | 11.06 M | 11.05 M | 2.23 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.